136 related articles for article (PubMed ID: 16597601)
1. The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe.
Mazhar D; Stebbing J; Lewis R; Nelson M; Gazzard BG; Bower M
Blood; 2006 Apr; 107(8):3412-4. PubMed ID: 16597601
[No Abstract] [Full Text] [Related]
2. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
Bleyer WA
Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743
[No Abstract] [Full Text] [Related]
3. [Association between meningeal Burkitt lymphoma and Epstein-Barr virus in an HIV-infected patient].
López G; Marcilla F; Ramos C; Arazo P
Enferm Infecc Microbiol Clin; 2007 Dec; 25(10):658. PubMed ID: 18053481
[No Abstract] [Full Text] [Related]
4. Neurological manifestations of HIV-1 infection in the HAART era.
Geraci AP; Simpson DM
Compr Ther; 2001; 27(3):232-41. PubMed ID: 11569325
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.
Duarte RF; Arnan M; Sánchez-Ortega I; de Llano MP; Abellán PF
Leuk Res; 2011 Jul; 35(7):e128-30. PubMed ID: 21501870
[No Abstract] [Full Text] [Related]
6. Immune recovery following antineoplastic chemotherapy and highly active antiretroviral therapy (HAART) in a child with HIV-1 infection previously unresponsive to HAART.
Galli L; Chiappini E; Lippi A; de Martino M
Int J Immunopathol Pharmacol; 2006; 19(4):919-22. PubMed ID: 17166413
[TBL] [Abstract][Full Text] [Related]
7. AIDS-related lymphomas--potentially curable in the HAART era.
Valencia ME
AIDS Rev; 2006; 8(2):108-10. PubMed ID: 16848278
[No Abstract] [Full Text] [Related]
8. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
[TBL] [Abstract][Full Text] [Related]
9. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
10. Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.
Spina M; Chimienti E; Martellotta F; Vaccher E; Berretta M; Zanet E; Lleshi A; Canzonieri V; Bulian P; Tirelli U
Cancer; 2010 Mar; 116(6):1495-501. PubMed ID: 20108270
[TBL] [Abstract][Full Text] [Related]
11. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
12. Management of HIV-associated Hodgkin lymphoma: how far we have come.
Kaplan LD
J Clin Oncol; 2012 Nov; 30(33):4056-8. PubMed ID: 23045587
[No Abstract] [Full Text] [Related]
13. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
14. [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
Guillaume C; Vegas H; Pastuszka A; Le Brun C; Lanotte P
Ann Biol Clin (Paris); 2018 Oct; 76(5):568-570. PubMed ID: 30154068
[TBL] [Abstract][Full Text] [Related]
15. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
Jaeckle KA; Batchelor T; O'Day SJ; Phuphanich S; New P; Lesser G; Cohn A; Gilbert M; Aiken R; Heros D; Rogers L; Wong E; Fulton D; Gutheil JC; Baidas S; Kennedy JM; Mason W; Moots P; Russell C; Swinnen LJ; Howell SB
J Neurooncol; 2002 May; 57(3):231-9. PubMed ID: 12125986
[TBL] [Abstract][Full Text] [Related]
16. Treatment options of AIDS-related lymphoma.
Schmidt-Wolf IG; Rockstroh JK; Schlegel U; Pels H; Mey U; Strehl J; Weiss R; Huhn D
Expert Opin Pharmacother; 2003 Aug; 4(8):1331-43. PubMed ID: 12877641
[TBL] [Abstract][Full Text] [Related]
17. [Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents].
Moreno L; García Ariza MA; Cruz O; Calvo C; Fuster JL; Salinas JA; Moscardo C; Portugal R; Merino JM; Madero L
An Pediatr (Barc); 2016 Nov; 85(5):274.e1-274.e8. PubMed ID: 27086069
[TBL] [Abstract][Full Text] [Related]
18. AIDS and cancer in the era of highly active antiretroviral therapy (HAART).
Rabkin CS
Eur J Cancer; 2001 Jul; 37(10):1316-9. PubMed ID: 11423263
[TBL] [Abstract][Full Text] [Related]
19. Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.
Glas M; Stuplich M; Tschampa H; Urbach H; Rasch K; Herrlinger U
J Neurol; 2008 Nov; 255(11):1838-9. PubMed ID: 18661166
[No Abstract] [Full Text] [Related]
20. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
Diamond C; Taylor TH; Im T; Anton-Culver H
Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]